228 related articles for article (PubMed ID: 25156132)
21. MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome.
Glintborg D; Andersen M
Eur J Endocrinol; 2017 Feb; 176(2):R53-R65. PubMed ID: 27601016
[TBL] [Abstract][Full Text] [Related]
22. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
de Wilde MA; Veltman-Verhulst SM; Goverde AJ; Lambalk CB; Laven JS; Franx A; Koster MP; Eijkemans MJ; Fauser BC
Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
Cussons AJ; Stuckey BG; Watts GF
Atherosclerosis; 2006 Apr; 185(2):227-39. PubMed ID: 16313910
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
[TBL] [Abstract][Full Text] [Related]
25. Polycystic ovaries - beyond menopause.
Shah D; Bansal S
Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
27. Polycystic ovary syndrome, obesity and reproductive implications.
Hirschberg AL
Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
[TBL] [Abstract][Full Text] [Related]
28. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
Wild S; Pierpoint T; McKeigue P; Jacobs H
Clin Endocrinol (Oxf); 2000 May; 52(5):595-600. PubMed ID: 10792339
[TBL] [Abstract][Full Text] [Related]
30. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
31. [Polycystic ovary syndrome and pregnancy: clinical experience].
Villarroel AC; Echiburú B; Riesco V; Maliqueo M; Cárcamo M; Hitschfeld C; Sánchez F; del Solar MP; Sir-Petermann T
Rev Med Chil; 2007 Dec; 135(12):1530-8. PubMed ID: 18357353
[TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome and female reproduction.
Elghblawi E
Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovarian syndrome.
Trikudanathan S
Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
[TBL] [Abstract][Full Text] [Related]
34. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
35. Management of Women with Polycystic Ovary Syndrome During Pregnancy.
Valent AM; Barbour LA
Endocrinol Metab Clin North Am; 2021 Mar; 50(1):57-69. PubMed ID: 33518186
[TBL] [Abstract][Full Text] [Related]
36. [Polycystic ovary syndrome and pregnancy].
Sir-Petermann T; Ladrón de Guevara A; Villarroel AC; Preisler J; Echiburú B; Recabarren S
Rev Med Chil; 2012 Jul; 140(7):919-25. PubMed ID: 23282707
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada R; Williams T
FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.
Morgan CL; Jenkins-Jones S; Currie CJ; Rees DA
J Clin Endocrinol Metab; 2012 Sep; 97(9):3251-60. PubMed ID: 22767635
[TBL] [Abstract][Full Text] [Related]
39. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
Popovska-Dimova Z; Krstevska B
Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
[TBL] [Abstract][Full Text] [Related]
40. [Long-term consequences of polycystic ovary syndrome].
Grigoryan OR; Zhemaite NS; Volevodz NN; Andreeva EN; Melnichenko GA; Dedov II
Ter Arkh; 2017; 89(10):75-79. PubMed ID: 29171475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
